Yao Wenlong, Ye Xin-Shan
State Key Laboratory of Natural and Biomimetic Drugs, School of Pharmaceutical Sciences, and Chemical Biology Center, Peking University, Xue Yuan Road No. 38, Beijing 100191, China.
National Research Center for Carbohydrate Synthesis, Jiangxi Normal University, Nanchang 330022, China.
Acc Chem Res. 2024 Jun 4;57(11):1577-1594. doi: 10.1021/acs.accounts.4c00072. Epub 2024 Apr 15.
Carbohydrates are called the third chain of life. Carbohydrates participate in many important biochemical functions in living species, and the biological information carried by them is several orders of magnitude larger than that of nucleic acids and proteins. However, due to the intrinsic complexity and heterogeneity of carbohydrate structures, furnishing pure and structurally well-defined glycans for functional studies is a formidable task, especially for homogeneous large-size glycans. To address this issue, we have developed a donor preactivation-based one-pot glycosylation strategy enabling multiple sequential glycosylations in a single reaction vessel.The donor preactivation-based one-pot glycosylation refers to the strategy in which the glycosyl donor is activated in the absence of a glycosyl acceptor to generate a reactive intermediate. Subsequently, the glycosyl acceptor with the same anomeric leaving group is added, leading to a glycosyl coupling reaction, which is then iterated to rapidly achieve the desired glycan in the same reactor. The advantages of this strategy include the following: (1) unique chemoselectivity is obtained after preactivation; (2) it is independent of the reactivity of glycosyl donors; (3) multiple-step glycosylations are enabled without the need for intermediate purification; (4) only stoichiometric building blocks are required without complex protecting group manipulations. Using this protocol, a range of glycans including tumor-associated carbohydrate antigens, various glycosaminoglycans, complex -glycans, and diverse bacterial glycans have been synthesized manually. Gratifyingly, the synthesis of mycobacterial arabinogalactan containing 92 monosaccharide units has been achieved, which created a precedent in the field of polysaccharide synthesis. Recently, the synthesis of a highly branched arabinogalactan from traditional Chinese medicine featuring 140 monosaccharide units has been also accomplished to evaluate its anti-pancreatic-cancer activity. In the spirit of green and sustainable chemistry, this strategy can also be applied to light-driven glycosylation reactions, where either UV or visible light can be used for the activation of glycosyl donors.Automated synthesis is an advanced approach to the construction of complex glycans. Based on the two preactivation modes (general promoter activation mode and light-induced activation mode), a universal and highly efficient automated solution-phase synthesizer was further developed to drive glycan assembly from manual to automated synthesis. Using this synthesizer, a library of oligosaccharides covering various glycoforms and glycosidic linkages was assembled rapidly, either in a general promoter-activation mode or in a light-induced-activation mode. The automated synthesis of a fully protected fondaparinux pentasaccharide was realized on a gram scale. Furthermore, the automated synthesis of large-size polysaccharides was performed, allowing the assembly of arabinans up to an astonishing 1080-mer using the automated multiplicative synthesis strategy, taking glycan synthesis to a new height far beyond the synthesis of nucleic acids (up to 200-mer) and proteins (up to 472-mer).
碳水化合物被称为生命的第三条链。碳水化合物参与生物体内许多重要的生化功能,其携带的生物信息比核酸和蛋白质大几个数量级。然而,由于碳水化合物结构固有的复杂性和异质性,为功能研究提供纯净且结构明确的聚糖是一项艰巨的任务,尤其是对于均一的大尺寸聚糖。为了解决这个问题,我们开发了一种基于供体预活化的一锅法糖基化策略,能够在单个反应容器中进行多次连续糖基化反应。基于供体预活化的一锅法糖基化是指在没有糖基受体的情况下激活糖基供体以生成反应性中间体的策略。随后,加入具有相同异头离去基团的糖基受体,引发糖基偶联反应,然后重复该反应,在同一反应器中快速得到所需的聚糖。该策略的优点包括:(1)预活化后获得独特的化学选择性;(2)与糖基供体的反应性无关;(3)无需中间体纯化即可进行多步糖基化反应;(4)仅需化学计量的构建单元,无需复杂的保护基操作。使用该方法,已经人工合成了一系列聚糖,包括肿瘤相关碳水化合物抗原、各种糖胺聚糖、复杂聚糖和多种细菌聚糖。令人欣慰的是,已经实现了含有92个单糖单元的分枝杆菌阿拉伯半乳聚糖的合成,这在多糖合成领域开创了先例。最近,还完成了一种来自中药的具有140个单糖单元的高度分支阿拉伯半乳聚糖的合成,以评估其抗胰腺癌活性。本着绿色和可持续化学的精神,该策略也可应用于光驱动糖基化反应,其中紫外光或可见光均可用于激活糖基供体。自动化合成是构建复杂聚糖的先进方法。基于两种预活化模式(通用启动子激活模式和光诱导激活模式),进一步开发了一种通用且高效的自动化溶液相合成仪,以推动聚糖组装从手动合成向自动化合成发展。使用该合成仪,无论是在通用启动子激活模式还是光诱导激活模式下,都能快速组装涵盖各种糖型和糖苷键的寡糖库。实现了克级规模的完全保护的磺达肝癸五糖的自动化合成。此外,还进行了大尺寸多糖的自动化合成,利用自动化倍增合成策略能够组装出高达惊人的1080聚体的阿拉伯聚糖,将聚糖合成提升到一个远超核酸(高达200聚体)和蛋白质(高达472聚体)合成的新高度。